Narayana Hrudayalaya Ltd.

The investor presentation for Narayana Hrudayalaya Ltd. (NH) for Q2 FY27 highlights operational and financial performance, strategic initiatives, and ESG goals. Operationally, NH achieved milestones such as performing South India’s first Percutaneous Transcatheter Tricuspid Valve Replacement and managing complex surgeries. Financially, consolidated operating revenues reached ₹28,440 Mn, up 73.0% YoY, with an EBITDA of ₹6,054 Mn (21.3% margin) and PAT of ₹3,012 Mn (10.6% margin). The company reported a net debt-to-equity ratio of 0.38 as of 30 September 2026. Expansion plans include new hospitals in Bangalore, Kolkata, and Raipur, with a total capex of ₹7,800+ Mn. Digital initiatives aim to digitize patient journeys, reducing paper usage. ESG goals include training 25,000+ healthcare professionals by 2030 and achieving 50% renewable energy by 2030. Shareholding as of 30 September 2026 shows promoters holding 63.3%, with key DIIs and FIIs holding the remaining shares. The document includes forward-looking statements and disclaimers about potential variations in actual results.

The document emphasizes operational achievements, financial growth, and strategic expansion, reflecting a positive outlook.